Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report

Fig. 2

Consecutive CT scans obtained from the patient: AFK – before introduction of IFN-alpha (14-Jan-2013), BGL – during treatment with subcutaneous IFN-alpha (11-Apr-2013), CHM – during treatment with subcutaneous IFN-alpha (6-May-2013), DIN – before introduction of inhaled IFN-alpha (27-May-2013), EJO – during treatment with subcutaneous IFN-alpha and inhaled IFN-alpha (27-Jun-2013)

Back to article page